Related Experiment Video
Updated: Jul 31, 2026

05:37
Intravitreous Injection for Establishing Ocular Diseases Model
Published on: October 1, 2007
Intravitreal injections by a Dermojet syringe
Summary
The Dermojet device, used for accidental intraocular injection, showed no adverse effects in experimental rabbit eye injections. Further research is needed before human use.
Area of Science:
- Ophthalmology
- Medical Devices
- Pharmacology
Background:
- The Dermojet is a spring-loaded device designed for high-velocity microspray injections.
- An accidental intraocular injection of triamcinolone acetonide occurred with a Dermojet syringe.
Purpose of the Study:
- To evaluate the safety and effects of intravitreal injections using the Dermojet device in an animal model.
- To assess the potential of the Dermojet for ocular drug delivery.
Main Methods:
- Intravitreal injections were performed in 7 rabbit eyes using the Dermojet syringe.
- Normal saline was used as the vehicle in 6 eyes, and India ink in one eye.
- Clinical and histopathological examinations were conducted to assess effects.
Main Results:
- No irreversible clinical or histopathological effects were observed in the rabbit eyes post-injection.
- The Dermojet device demonstrated a lack of immediate adverse effects in this experimental setting.
Conclusions:
- The Dermojet device may have potential for intravitreal injections, but requires further modification and animal experimentation.
- Current evidence suggests the Dermojet should not be used for human ocular injections at this time.
Related Concept Videos
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

